Cargando…
Association of Influenza Vaccination and Prognosis in Patients Testing Positive to SARS-COV-2 Swab Test: A Large-Scale Italian Multi-Database Cohort Study
To investigate the association of the 2019–2020 influenza vaccine with prognosis of patients positive for SARS-CoV-2A, a large multi-database cohort study was conducted in four Italian regions (i.e., Lazio, Lombardy, Veneto, and Tuscany) and the Reggio Emilia province (Emilia-Romagna). More than 21...
Autores principales: | Massari, Marco, Spila-Alegiani, Stefania, Fabiani, Massimo, Belleudi, Valeria, Trifirò, Gianluca, Kirchmayer, Ursula, Poggi, Francesca Romana, Mancuso, Pamela, Menniti-Ippolito, Francesca, Gini, Rosa, Bartolini, Claudia, Leoni, Olivia, Ercolanoni, Michele, Da-Re, Filippo, Guzzinati, Stefano, Luxi, Nicoletta, Riccardo, Flavia, Giorgi-Rossi, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310185/ https://www.ncbi.nlm.nih.gov/pubmed/34358133 http://dx.doi.org/10.3390/vaccines9070716 |
Ejemplares similares
-
Postmarketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12 to 39 years in Italy: A multi-database, self-controlled case series study
por: Massari, Marco, et al.
Publicado: (2022) -
Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Death in Patients Hospitalised with COVID-19: A Retrospective Italian Cohort Study of 43,000 Patients
por: Trifirò, Gianluca, et al.
Publicado: (2020) -
Postmarketing observational study on the safety of 2021/2022 and 2022/2023 influenza vaccination campaigns in Italy: TheShinISS-Vax|Flu study protocol
por: Spila Alegiani, Stefania, et al.
Publicado: (2023) -
Survival of Hospitalized COVID-19 Patients in Northern Italy: A Population-Based Cohort Study by the ITA-COVID-19 Network
por: Ferroni, Eliana, et al.
Publicado: (2020) -
Risk of SARS-CoV-2 infection and subsequent hospital admission and death at different time intervals since first dose of COVID-19 vaccine administration, Italy, 27 December 2020 to mid-April 2021
por: Mateo-Urdiales, Alberto, et al.
Publicado: (2021)